US OptionsDetailed Quotes
ABCL250417P4000
- 1.90
- 0.000.00%
15min DelayClose Apr 17 16:00 ET
0.00High0.00Low
1.90Open1.90Pre Close0 Volume310 Open Interest4.00Strike Price0.00Turnover0.00%IV13.22%PremiumApr 17, 2025Expiry Date1.58Intrinsic Value100Multiplier0DDays to Expiry0.32Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.59Leverage Ratio--Theta--Rho--Eff Leverage--Vega
AbCellera Biologics Stock Discussion
Sign in to post a comment
The attention of AI Medteck stocks are rapidly increasing.
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...
116
14
285
US Congress member Nancy Pelosi and Ark Invest's Cathie Wood both bet big on an AI stock recently.
The stock in question is $Tempus AI (TEM.US)$, a company that uses data and artificial intelligence (AI) to create precision medicine services. ARK Invest, a prominent advocate for innovative technologies, first showed interest on December 6, when it purchased shares in this healthcare technology firm. Since that initial investment, Tempus AI h...
The stock in question is $Tempus AI (TEM.US)$, a company that uses data and artificial intelligence (AI) to create precision medicine services. ARK Invest, a prominent advocate for innovative technologies, first showed interest on December 6, when it purchased shares in this healthcare technology firm. Since that initial investment, Tempus AI h...
45
7
154
He added:
$iShares Russell 2000 ETF (IWM.US)$ —> $664M worth of calls, this to me is incredible…he really sees the broadening of this market to small caps
$Spdr Series Trust S&P Regional Bkg Etf (KRE.US)$ —> 307K shares, Stan likes regional banks…
$Reddit (RDDT.US)$ Reddit —> 175K shares, seems like he saw the need for real time data from platforms like Reddit
$Palo Alto Networks (PANW.US)$ Palo Alto Networks —> 74K sha...
$iShares Russell 2000 ETF (IWM.US)$ —> $664M worth of calls, this to me is incredible…he really sees the broadening of this market to small caps
$Spdr Series Trust S&P Regional Bkg Etf (KRE.US)$ —> 307K shares, Stan likes regional banks…
$Reddit (RDDT.US)$ Reddit —> 175K shares, seems like he saw the need for real time data from platforms like Reddit
$Palo Alto Networks (PANW.US)$ Palo Alto Networks —> 74K sha...
11
» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...
10
2
How does the biotech ecosystem support advancements in personalized medicine & genomics? ![]()
• Editing Genes | $CRISPR Therapeutics (CRSP.US)$ , $Intellia Therapeutics (NTLA.US)$ , $Beam Therapeutics (BEAM.US)$ , $Verve Therapeutics (VERV.US)$ , $Editas Medicine (EDIT.US)$
• Creating Therapies | $Prime Medicine (PRME.US)$ , $Sana Biotechnology (SANA.US)$
• Building DNA | $Twist Bioscience (TWST.US)$ , $Ginkgo Bioworks (DNA.US)$ , $Pacific Biosciences of California (PACB.US)$ , $Illumina (ILMN.US)$
• Dis...
• Editing Genes | $CRISPR Therapeutics (CRSP.US)$ , $Intellia Therapeutics (NTLA.US)$ , $Beam Therapeutics (BEAM.US)$ , $Verve Therapeutics (VERV.US)$ , $Editas Medicine (EDIT.US)$
• Creating Therapies | $Prime Medicine (PRME.US)$ , $Sana Biotechnology (SANA.US)$
• Building DNA | $Twist Bioscience (TWST.US)$ , $Ginkgo Bioworks (DNA.US)$ , $Pacific Biosciences of California (PACB.US)$ , $Illumina (ILMN.US)$
• Dis...
9
2
Insiders at AbCellera Biologics Inc. are increasing their holdings, indicating optimism about the company's prospects. Their willingness to buy shares at a higher price suggests they see value in the company.
1
KeyBanc views current lower subsector stock prices as a valuable opportunity for long-term investors. The bank advises a detailed, company-specific approach to investment, highlighting Abcellera ($6), Absci ($3), and Schrodinger ($38) for their proven track records, AI focus, and recurring revenue growth, respectively.
1
$AbCellera Biologics (ABCL.US)$ Director Montalbano John S. purchased 30,000 shares of Common Stocks on Nov 6, 8, 2023 at an average price of $4.58 for a total value of $137.4K.![]()
1
7
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
No comment yet
Buy n Die Together❤ :
73610841 : Adrian Nathaniel carter, I can’t tag him and we’re Facebook friends, does anyone know why?
Seth Beaty : Though you know if you bet against Cathie Wood, you’ll probably make money.
Rob banks : is there an ETF for this ai medical sector?
Chak : is it goid time yo
get into TEM ?
View more comments...